Shockwave Medical Inc (SWAV)
330.38
+0.38
(+0.12%)
USD |
NASDAQ |
May 03, 16:00
330.38
0.00 (0.00%)
After-Hours: 20:00
Shockwave Medical Cash and Short Term Investments (Quarterly): 990.55M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 990.55M |
September 30, 2023 | 917.33M |
June 30, 2023 | 258.59M |
March 31, 2023 | 416.86M |
December 31, 2022 | 304.49M |
September 30, 2022 | 250.67M |
June 30, 2022 | 224.91M |
March 31, 2022 | 201.13M |
December 31, 2021 | 200.98M |
September 30, 2021 | 182.95M |
June 30, 2021 | 174.75M |
Date | Value |
---|---|
March 31, 2021 | 177.43M |
December 31, 2020 | 202.35M |
September 30, 2020 | 215.26M |
June 30, 2020 | 231.40M |
March 31, 2020 | 170.39M |
December 31, 2019 | 195.35M |
September 30, 2019 | 114.10M |
June 30, 2019 | 125.14M |
March 31, 2019 | 138.06M |
December 31, 2018 | 39.64M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
114.10M
Minimum
Sep 2019
990.55M
Maximum
Dec 2023
292.35M
Average
202.35M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
Boston Scientific Corp | 2.329B |
AtriCure Inc | 105.96M |
Masimo Corp | 163.00M |
Perspective Therapeutics Inc | 9.238M |
Xtant Medical Holdings Inc | 5.715M |